Helix BioPharma Corp. (HBP.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
At close: 03:49PM EDT
| Previous Close | 0.2450 |
| Open | 0.2450 |
| Bid | 0.2450 x 0 |
| Ask | 0.2500 x 0 |
| Day's Range | 0.2450 - 0.2500 |
| 52 Week Range | 0.1700 - 0.9500 |
| Volume | |
| Avg. Volume | 25,445 |
| Market Cap | 43.586M |
| Beta (5Y Monthly) | -0.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0560 |
| Earnings Date | Jun 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Insiders may be rethinking their CA$3.0m Helix BioPharma Corp. (TSE:HBP) investment now that the company has lost CA$5.0m in value
Insiders who bought CA$3.0m worth of Helix BioPharma Corp.'s ( TSE:HBP ) stock at an average buy price of CA$0.26 over...
- ACCESSWIRE
Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.
VANCOUVER, BC / ACCESSWIRE / April 22, 2022 / Mr. Jerzy Wilczewski announces the acquisition of 7,700,000 common shares ("Common Shares") in the capital of Helix Biopharma Corp.
- ACCESSWIRE
Helix Biopharma Corp. Closes Private Placement
RICHMOND HILL, ON / ACCESSWIRE / April 21, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47, today announces that it has closed a private placement financing for net proceeds of $2,002,000 from the issuance of 7,700,000 common shares at a price of $0.
© 2022 Yahoo. All rights reserved.
